Seeking Alpha

U.S. growth for prescription drug sales is expected to slow to 1-2%. That's why Big Pharma firms...

U.S. growth for prescription drug sales is expected to slow to 1-2%. That's why Big Pharma firms (JNJ, PFE, MRK, WYE) are turning to emerging markets, where sales of Western prescription drugs are expected to grow by up to 15% a year to as much as $161B.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs